48–96 Hour Bravo pH Test for Patients: Ask About Meds, Diary, Safety
The Bravo pH test is a minimally invasive, wireless capsule based pH monitoring procedure that measures how often stomach acid reaches the esophagus over 48 to 96 hours and helps diagnose or monitor GERD. It is used to confirm reflux, link symptoms to acid events, and check whether treatment is working. The resulting acid exposure time guides whether a patient needs medication changes, further testing, or a different treatment path entirely.
TL;DR: The success of the test heavily depends on maintaining an accurate and timed symptom diary, not just capsule placement. Testing on or off medication must be carefully chosen based on the specific clinical question to avoid misinterpretation. The key measurement, acid exposure time, predicts whether patients can safely stop medication, with less than 4% time indicating better outcomes. Patients with nickel allergies, implanted electronic devices, or undergoing MRI should discuss options before scheduling. The capsule remains attached for up to 10 days, but the symptom diary and medication protocol are the most critical factors in obtaining reliable results.
Precision Digestive HealthDiscuss Your Reflux Testing OptionsPrecision Digestive Health provides GERD management and specialized gastroenterology care for adults seeking answers about digestive symptoms.Schedule an appointment
Table of Contents
- How the Bravo system works and why doctors use wireless monitoring
- Who should get tested and who should not
- Preparing for the Bravo test: medications, fasting, and logistics
- What happens during placement and the days that follow
- Making the monitoring period count: diary, diet, and red flags
- Risks, the FDA advisory, and what to ask before your test
- How doctors read your Bravo results
- A gastroenterologist’s view on when Bravo testing makes sense
- What this test actually gets right, and where patients overthink it
- Scheduling a Bravo test with our practice
- Sources
- FAQ
How the Bravo system works and why doctors use wireless monitoring
The Bravo capsule is a small sensor clipped to the lining of the lower esophagus during an upper endoscopy. It transmits pH readings by radio signal to a receiver the patient wears, so there is no tube hanging out of the nose during the recording period. This contrasts with catheter based pH-impedance testing, which threads a thin tube through the nostril and can detect non-acid reflux at multiple points along the esophagus, something the single-site Bravo capsule does not do. The tradeoff is comfort for scope: Bravo allows up to 96 hours of monitoring, which captures more day-to-day variation in symptoms than a shorter catheter study typically does.
Who should get tested and who should not
Doctors typically order Bravo testing for persistent heartburn, regurgitation, unexplained chest pain, evaluation before anti-reflux surgery, or to check whether a PPI is actually controlling acid exposure. Depending on the question being asked, the ordering clinician will choose between testing a patient off acid suppressing medication, to diagnose untreated reflux, or on therapy, to confirm control, and that choice shapes how the results get interpreted. The test is generally avoided in people with esophageal strictures or varices, a known nickel allergy, certain implanted electronic devices, or anyone unable to follow monitoring instructions at home.
Preparing for the Bravo test: medications, fasting, and logistics
Preparation hinges on the medication protocol your clinician selects. Clinicians commonly ask patients to stop acid suppressing medication for about one week before a diagnostic study, but you should never stop a PPI or H2 blocker on your own. Preparation also follows standard endoscopy prep guidelines for fasting and sedation.
- Confirm with your clinician whether you should stop or continue acid-reducing medications before the test.
- Bring a full list of medications, supplements, and known allergies to your pre-procedure visit.
- Arrange for an adult driver, since you will be sedated for capsule placement.
- Tell the clinic about any implanted electronic device or nickel allergy before scheduling.
- Ask the facility to confirm its Bravo delivery devices are not part of the FDA early-alert affecting certain capsule delivery systems.
Our endoscopy preparation workflow covers the fasting window and day-of logistics in more detail.
What happens during placement and the days that follow
Capsule placement happens during an upper endoscopy (EGD), with sedation to keep you comfortable while the physician positions and attaches the sensor to the esophageal wall.
- The physician passes an endoscope and delivery catheter through the mouth, attaches the capsule to the esophagus, and withdraws the catheter.
- You recover briefly from sedation, then receive a small receiver to wear and instructions for logging symptoms.
- You go home and resume most normal activities while the capsule transmits pH data for up to 96 hours.
- You return the receiver to the clinic on the date given, and the capsule itself detaches on its own within about a week to ten days and passes naturally through the digestive tract.
Making the monitoring period count: diary, diet, and red flags
The value of a Bravo study depends on how well you log what you are doing while it records; using a symptom diary for patients can greatly aid in accurate monitoring and communication with your doctor. Institutional guidance emphasizes that accurate notes on meals, posture, sleep, and symptoms let your doctor match pH dips to what was actually happening in your day.
- Press the recorder button and note the time whenever you eat, lie down, or feel a symptom.
- Eat and move as you normally would unless your clinician told you otherwise.
- Keep taking or holding medications exactly as instructed for the testing window, not based on how you feel.
Pro Tip: Write down the clock time, not just “after lunch,” since even a 20-minute gap can change which acid event a symptom gets matched to.
Seek care promptly for severe chest pain, trouble swallowing, vomiting blood, black stools, or breathing difficulty during the monitoring period.
Risks, the FDA advisory, and what to ask before your test
Most patients notice only mild throat or chest discomfort for a day or two after placement. Rarely, the capsule fails to detach on its own and requires a follow-up endoscopy to remove it. Patients with an MRI scheduled should wait until the capsule has passed, since it is not MRI safe while attached, and anyone with a nickel allergy or certain implanted electronic devices should discuss alternatives with their clinician before scheduling.
- Capsule-related discomfort is usually brief and resolves without intervention.
- MRI scans should be postponed until the capsule has detached and passed.
- Implanted electronic devices and nickel allergies both warrant a conversation with your clinician beforehand.
The FDA issued an early-alert about certain Bravo CF capsule delivery devices that may fail to attach or detach as intended, and facilities were told to identify, quarantine, and replace affected units. Ask your facility to confirm it is using cleared, non-affected equipment before your procedure.
How doctors read your Bravo results
Interpretation centers on acid exposure time, or AET: the percentage of total monitoring time your esophageal pH stayed below 4, the threshold at which reflux is considered acidic. The DeMeester score folds several reflux measurements into one number clinicians use alongside AET. Research on PPI-resistant GERD patients found that a total or daily AET of 4.0% or less is associated with better odds of successfully stopping a PPI, while AET above 10.0% or a DeMeester score above 50 predicts that therapy will likely need to resume. The same research found that 96-hour monitoring gives better predictive power than shorter recording windows, particularly when the question is whether a patient can safely come off medication. Depending on where your numbers land, your doctor may adjust your medication, order additional testing for non-acid reflux, or discuss surgical options. For broader context on treatment paths after a GERD diagnosis, see our guide to treating acid reflux in adults.
A gastroenterologist’s view on when Bravo testing makes sense
Dr. Parikh orders Bravo testing when a patient’s symptoms do not match the response expected from standard acid suppression, or when a patient and physician are weighing whether it is safe to stop a PPI long term. The report he reviews focuses on total AET, symptom correlation, and whether reflux events cluster around meals or sleep, since that pattern often points to the next step in care. Before scheduling, the practice confirms medication timing with each patient and checks that capsule delivery equipment is current and unaffected by any manufacturer notice.
What this test actually gets right, and where patients overthink it
The most overrated part of Bravo testing is the capsule itself. Patients worry about the device, when the real variable that determines whether the test is useful is the quality of the symptom diary kept during those 48 to 96 hours. A near-perfect capsule placement paired with vague, untimed notes produces a report a physician cannot confidently act on.
The medication decision deserves more attention than it usually gets. Whether you test on or off acid suppressing therapy changes what the numbers mean, and patients sometimes assume stopping their PPI is simply what everyone does. It is not: it depends entirely on the clinical question being asked, and getting it backward can produce a result that answers the wrong question.
If you take one thing from this test, make it the diary. Log the time, not just the activity, and treat the FDA’s equipment notice as a normal pre-procedure question to ask, not a reason for alarm.
— Precision Digestive Health
Scheduling a Bravo test with our practice
If persistent heartburn or an uncertain PPI response has you considering this test, our services page outlines scheduling steps, what to bring to your pre-procedure visit, and how insurance verification works before the day of your upper endoscopy. Capsule delivery equipment is confirmed current before every placement and results are discussed with patients after the recording period ends. Reach out with any safety or coverage questions specific to your case.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Sources
- Esophageal pH monitoring capsule recall: Medtronic and Given Imaging (FDA)
- Wireless esophageal pH test (Johns Hopkins Medicine)
- BRAVO off medication (Stony Brook Medicine patient instruction PDF)
- Gi
FAQ
Is the Bravo pH test worth it for diagnosing reflux?
For patients with persistent symptoms or an uncertain response to medication, Bravo testing gives objective acid exposure data that a symptom description alone cannot. It is especially useful when a doctor needs to decide whether to continue, adjust, or stop reflux medication.
Is the Bravo test covered by insurance?
Coverage depends on your individual insurance plan and the medical necessity documented by your physician. Insurance details for Bravo testing are typically verified prior to scheduling; patients should contact the provider directly for specific information.
How much does a Bravo pH monitoring test cost?
Pricing for Bravo testing varies with insurance coverage and individual circumstances; it is recommended to discuss costs directly with the billing team before the procedure.
What is considered normal pH on a Bravo test?
A normal result generally shows low acid exposure time, with total or daily AET at or below 4.0% associated with better odds of a normal reflux profile and successful discontinuation of acid-suppressing medication.
How long does the entire Bravo testing process take?
The capsule itself records for up to 96 hours, after which you return the receiver and your physician reviews the data, typically discussing results at a follow-up visit. The capsule detaches and passes on its own within about a week to ten days after placement.
